Application of a nomogram for exercise capacity in women with systemic lupus erythematosus

Clinical Rheumatology

Volumn 28, Issue 6, 2009, Pages 719-722

  Hazel, E M ^a   Bernatsky, Sasha ^a,b   Da Costa, D ^b   Dasgupta, K ^b   Clarke, A E ^a,b   Joseph, L ^b   St Pierre, Y ^b   Pineau, C A ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Cardiac risk; Exercise capacity; Nomogram; SLE; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ACTIVITY; EXERCISE; EXERCISE TEST; FEMALE; FITNESS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; NOMOGRAM; PHYSICAL PERFORMANCE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CORONARY ARTERY DISEASE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; NOMOGRAMS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 67349281954     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1113-3     Document Type: Article

References (15)

1. Petri M, Perez-Gutthann S, Spence D, Hochberg MC (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513-519
2. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:221-225
3. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L et al (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study. Am J Epidemiol 145:408-415
4. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S et al (2003) Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 349:2407-2415
5. Rahman P, Urowitz MB, Gladman DD, Bruce IN (1999) Contribution of traditional risk factors to coronary artery disease in patients with SLE. J Rheumatol 26:2363-2368
6. Petri M, Kiani AN Post W Magder L (2006) Lupus atherosclerosis prevention study (LAPS): A randomized double blind placebo controlled trial of atorvastatin versus placebo. Arthritis Rheum 54:S520
7. Toloza S, Urowitz MB, Gladman DD (2007) Should all patients with systemic lupus erythematosus receive cardioprotection with statins? Nat Clin Pract Rheumatol 3:536-537
8. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, Du BR et al (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44:2331-2337
9. Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, Sheps DS (1988) Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. The Lipid Research Clinics Mortality Follow-up Study. N Engl J Med 319:1379-1384
10. Tench C, Bentley D, Vleck V, McCurdie I, White P, D'Cruz D (2002) Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus. J Rheumatol 29:474-481
11. Keyser RE, Rus V, Cade WT, Kalappa N, Flores RH, Handwerger BS (2003) Evidence for aerobic insufficiency in women with systemic Lupus erythematosus. Arthritis Rheum 49:16-22
12. Gulati M, Black HR, Shaw LJ, Arnsdorf MF, Merz CN, Lauer MS et al (2005) The prognostic value of a nomogram for exercise capacity in women. N Engl J Med. 353:468-475
13. Gulati M, Pandey DK, Arnsdorf MF, Lauderdale DS, Thisted RA, Wicklund RH et al (2003) Exercise capacity and the risk of death in women: The St James Women Take Heart Project. Circulation 108:1554-1559
14. Bruce IN (2005) 'Not only...but also': Factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology (Oxford) 44:1492-1502
15. Bruce IN, Gladman DD, Urowitz MB (1998) Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: A quality improvement study. Clin Exp Rheumatol 16:435-440